BALA CYNWYD, PA--(Marketwire - October 11, 2007) - Duska Therapeutics, Inc. (“Duska” or the “Company”) (OTCBB: DSKA), a biopharmaceutical company developing new medicines to treat cardiovascular diseases, announced today the appointment of H. David Coherd to the board of directors. Mr. Coherd is a co-founder and Managing Director of Growth Capital Partners, LLC, an investment banking firm. He oversees public and private healthcare for the firm. He is also the managing member of BioMed Cap, LLC, a firm focused on life science investing.
